Audit 330169

FY End
2024-06-30
Total Expended
$24.97M
Findings
0
Programs
14
Year: 2024 Accepted: 2024-11-27
Auditor: Armanino

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.859 Biomedical Research and Research Training $511,301 Yes 0
93.855 Allergy and Infectious Diseases Research $394,575 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $326,620 Yes 0
93.121 Oral Diseases and Disorders Research $250,369 Yes 0
12.420 Military Medical Research and Development $204,110 Yes 0
93.279 Drug Abuse and Addiction Research Programs $129,914 Yes 0
47.074 Biological Sciences $115,061 Yes 0
43.003 Exploration $99,870 Yes 0
93.310 Trans-Nih Research Support $73,809 Yes 0
93.394 Cancer Detection and Diagnosis Research $55,383 Yes 0
93.396 Cancer Biology Research $54,323 Yes 0
93.838 Lung Diseases Research $41,005 Yes 0
93.866 Aging Research $34,312 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $31,482 Yes 0

Contacts

Name Title Type
WMHWCFJNAJL3 Theresa Fischer Auditee
4155051270 Grant Lam Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the "Schedule") has been prepared on the accrual basis and in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The purpose of the Schedule is to present a summary of those activities of the Institute for the year ended June 30, 2024, which have been financed by the U.S. Government. For purposes of the Schedule, federal awards include all federal assistance entered into directly between the Institute and the federal government as well as assistance passed through to the Institute. Because the Schedule presents only the federal award activity of the Institute, it is not intended to and does not present the financial position, the changes in net assets or the cash flows of the Institute for the year ended June 30, 2024. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or limited as to reimbursement. Passthrough entity identifying numbers are presented where available and applicable. De Minimis Rate Used: N Rate Explanation: The Institute uses its negotiated indirect cost rate when charging indirect costs to federal awards rather than the 10% de minimis rate allowed by the Uniform Guidance.